Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93,227,509
-
Total 13F shares
-
73,860,328
-
Share change
-
-1,313,532
-
Total reported value
-
$2,248,603,947
-
Put/Call ratio
-
68%
-
Price per share
-
$30.45
-
Number of holders
-
193
-
Value change
-
-$35,142,715
-
Number of buys
-
81
-
Number of sells
-
93
Institutional Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q1 2021
As of 31 Mar 2021,
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) was held by
193 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
73,860,328 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, EARNEST PARTNERS LLC, STATE STREET CORP, Camber Capital Management LP, BANK OF AMERICA CORP /DE/, DIMENSIONAL FUND ADVISORS LP, PFM Health Sciences, LP, D. E. Shaw & Co., Inc., and GLENVIEW CAPITAL MANAGEMENT, LLC.
This page lists
193
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.